Send feedback

BUB1B p.Arg349Gln

c.1046G>A · rs1801376 · VCV133780

Benign Multiple submitters
Classification
Benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 6 submitters
AlphaMissense
likely benign
0.0471 · ACMG-weighted
gnomAD v4.1
Common
common (popmax 82.5%, afr) — too common for a highly-penetrant pathogenic allele
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
mosaic variegated aneuploidy syndrome 1

Computational evidence

Protein change
AlphaMissense0.0471likely benign
REVEL0.061moderately benign-leaning
SaProtLLR -5.75tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 4GERP -0.073, phastCons 1
Regional constrainto/e 0.91unconstrained · MANE · 60 kb · p 0.0024 · regional, not allelic
Overall
CADD16.68PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 82.5% African / African-American · 61,867/74,990 alleles
Filtering AF 82% ClinGen BA1/BS1 input FAF95, joint · FAF99 81.7%
Overall 68.6% 1,106,736/1,612,848 alleles · common exomes 998,301/1,460,684 · genomes 108,435/152,164 · joint denominator
Ancestry group Frequency 1 in
Amishnot grpmax-eligible 84.6% 1
African / African-Americangrpmax 82.5% 1
Finnishnot grpmax-eligible 73.4% 1
European (non-Finnish) 70.6% 1
Remaining individualsnot grpmax-eligible 65.7% 2
Admixed American 62.1% 2
Ashkenazi Jewishnot grpmax-eligible 58.8% 2
South Asian 54.9% 2
Middle Eastern 54.5% 2
East Asian 34.7% 3

Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
BUB1B
Protein
p.Arg349Gln
Coding
c.1046G>A
MANE Select
NM_001211
dbSNP
rs1801376
Type
single nucleotide variant
Location
chr15:40185630 (GRCh38)
Gene constraint
LOEUF 0.707 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 64.62 · 9 PDB
Residue 349
a UniProt-annotated variant site (in)
Full BUB1B gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/bub1b-p-arg349gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown